|
TTK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.031220E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.636400E-02 |
| Normal-vs-Stage2 |
9.606000E-01 |
| Normal-vs-Stage3 |
1.070800E-01 |
| Normal-vs-Stage4 |
1.023640E-01 |
| Stage1-vs-Stage2 |
2.998300E-03 |
| Stage1-vs-Stage3 |
9.108800E-01 |
| Stage1-vs-Stage4 |
7.542600E-01 |
| Stage2-vs-Stage3 |
2.838000E-02 |
| Stage2-vs-Stage4 |
3.481900E-02 |
| Stage3-vs-Stage4 |
7.462400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.962500E-02 |
| Normal-vs-AfricanAmerican |
4.735600E-01 |
| Normal-vs-Asian |
1.510160E-01 |
| Caucasian-vs-AfricanAmerican |
5.517600E-01 |
| Caucasian-vs-Asian |
7.360800E-01 |
| AfricanAmerican-vs-Asian |
6.533800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.744000E-02 |
| Normal-vs-Female |
1.196570E-01 |
| Male-vs-Female |
6.965800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.053540E-02 |
| Normal-vs-Age(41-60Yrs) |
6.314000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.340400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.025360E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.418500E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.028020E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.199800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.684190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.143150E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.520240E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.803600E-01 |
| Classical-VS-Follicular |
1.873750E-02 |
| Classical-VS-Other |
1.782210E-01 |
| Classical-VS-Normal |
5.581700E-02 |
| Tall-VS-Follicular |
2.992000E-02 |
| Tall-VS-Other |
2.189200E-01 |
| Tall-VS-Normal |
3.932100E-02 |
| Follicular-VS-Other |
9.257200E-01 |
| Follicular-VS-Normal |
5.789600E-01 |
| Other-VS-Normal |
7.505200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.869240E-01 |
| Normal-vs-N1 |
1.796970E-01 |
| N0-vs-N1 |
7.418400E-01 |
|
|
